tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AQST Stock Latest News

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Press ReleasesAquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
25d ago
AQST
Aquestive reports topline data from temperature/pH study of Anaphylm
PremiumThe Fly
Aquestive reports topline data from temperature/pH study of Anaphylm
27d ago
AQST
Aquestive Therapeutics to join Russell 3000, Russell 2000 Indexes
PremiumThe Fly
Aquestive Therapeutics to join Russell 3000, Russell 2000 Indexes
1M ago
AQST
Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
PremiumPress Releases
Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
1M ago
AQST
Aquestive Therapeutics Shares Investor Presentation Update
PremiumCompany Announcements
Aquestive Therapeutics Shares Investor Presentation Update
2M ago
8K
AQST
Aquestive Therapeutics Appoints Cassie Jung as COO
PremiumCompany AnnouncementsAquestive Therapeutics Appoints Cassie Jung as COO
2M ago
8K
AQST
Aquestive Therapeutics appoints Cassie Jung as COO, Stephen Wargacki as CSO
PremiumThe Fly
Aquestive Therapeutics appoints Cassie Jung as COO, Stephen Wargacki as CSO
2M ago
AQST
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
PremiumPress Releases
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
2M ago
AQST
Aquestive Therapeutics to present Anaphylm sublingual film PK, PD data
PremiumThe Fly
Aquestive Therapeutics to present Anaphylm sublingual film PK, PD data
2M ago
AQST
Aquestive Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Aquestive Therapeutics initiated with an Outperform at Leerink
2M ago
AQST
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
PremiumPress Releases
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
2M ago
AQST
Aquestive Therapeutics price target lowered to $5.50 from $7 at Alliance Global Partners
PremiumThe Fly
Aquestive Therapeutics price target lowered to $5.50 from $7 at Alliance Global Partners
2M ago
AQST
Aquestive Therapeutics Presents to Investors and Analysts
PremiumCompany AnnouncementsAquestive Therapeutics Presents to Investors and Analysts
3M ago
8K
AQST
Aquestive Therapeutics sees FY24 revenue $48M-$51M, consensus $50.21M
PremiumThe Fly
Aquestive Therapeutics sees FY24 revenue $48M-$51M, consensus $50.21M
3M ago
AQST
Aquestive Therapeutics reports Q1 EPS (17c), consensus (8c)
PremiumThe Fly
Aquestive Therapeutics reports Q1 EPS (17c), consensus (8c)
3M ago
AQST
Aquestive Therapeutics Shares Investor Presentation Update
PremiumCompany Announcements
Aquestive Therapeutics Shares Investor Presentation Update
3M ago
8K
AQST
Aquestive Therapeutics options imply 12.3% move in share price post-earnings
PremiumThe Fly
Aquestive Therapeutics options imply 12.3% move in share price post-earnings
3M ago
AQST
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ALT
AQST
Aquestive Therapeutics receives FDA approval, market access for Libervant
PremiumThe Fly
Aquestive Therapeutics receives FDA approval, market access for Libervant
3M ago
AQST
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
GME
LAC
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
PremiumPress Releases
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
3M ago
AQST
Aquestive Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Aquestive Therapeutics initiated with an Overweight at Piper Sandler
3M ago
AQST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >